Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

Funding Agencies|Associazione Italiana per la Ricerca sul Cancro, Milan (AIRC-IG) [15333]
An increasing number of manuscripts focus on the in vitro evaluation of established and novel anti-tumor agents in experimental models. Whilst the design of such in vitro assays is inherently flexible, some of these studies lack the minimum information necessary to critically evaluate their relevance or have been carried out under unsuitable conditions. The use of appropriate and robust methods and experimental design has important implications for generating results that are reliable, relevant, and reproducible. The Pharmacology and Molecular Mechanisms (PAMM) group of the European Organization for Research and Treatment of Cancer (EORTC) is the largest group of academic scientists working on drug development and bundle decades of expertise in this field. This position paper addresses all researchers with an interest in the preclinical and cellular pharmacology of anti-tumor agents and aims at generating basic recommendations for the correct use of compounds to be tested for anti-tumor activity using a range of preclinical cellular models of cancer.

Hempel, GeorgWestfalische Wilhelms Univ Munster, Germany (författare)
Linder, StigKarolinska Institutet,Linköpings universitet,Avdelningen för läkemedelsforskning,Medicinska fakulteten,Karolinska Inst, Sweden(Swepub:liu)stili13 (författare)
Bradshaw, Tracey D.Univ Nottingham, England (författare)
Larsen, Annette K.INSERM U938, France; Sorbonne Univ, France (författare)
Peters, Godefridus J.Vrije Univ Amsterdam, Netherlands (författare)
Phillips, Roger M.Univ Huddersfield, England (författare)
Fdn IRCCS Ist Nazl Tumori, ItalyWestfalische Wilhelms Univ Munster, Germany (creator_code:org_t)

Ingår i:Cancer Chemotherapy and Pharmacology: SPRINGER81:3, s. 427-4410344-57041432-0843

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Medicinska och f ...; och Farmaceutiska ve ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.